hello world
Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.
Stocks in play: Satellos Bioscience Inc.
Announced today its financial results and corporate highlights for the three months ended September 30, 2024. Satellos reported a net loss of $9.0 million ($0.08 loss per share), compared to a net loss of $3.6 million ($0.03 loss per share) for the three months ended September 30, 2023. The increase in net loss for the three-month period ended September 30, 2024. Satellos Bioscience Inc. shares T.MSCL are trading unchanged at $0.84.
